An evidence-based comparison of cost, medication access, clinical oversight, and long-term value for adults seeking compounded GLP-1 therapy.
For patients who want transparent, all-inclusive pricing and dedicated weight-management support, Novolene delivers higher value: compounded semaglutide at $179/mo with no membership fees, no hidden costs, and free clinician messaging. Hims recently raised compounded semaglutide to $199/mo, discontinued its $49 oral GLP-1 pill after an FDA safety block, and is simultaneously defending a trademark lawsuit filed by Novo Nordisk—factors that may affect supply continuity and platform focus.
Prices captured April 2026; subject to change. Shipping, supplies, and clinician messaging are included with Novolene. Hims pricing reflects only GLP-1 subscription and does not include add-ons for hair, skin, or mental-health products.
When prepared by PCAB-accredited 503A/B pharmacies, compounded semaglutide uses the same active ingredient found in Wegovy® and Ozempic®. Clinical outcomes are comparable when paired with appropriate dose escalation and lifestyle counseling. Novolene sources only FDA-registered facilities that follow USP <795> & <797> standards.
In February 2026 the FDA concluded the product lacked substantial evidence of safety and efficacy for weight management. Hims voluntarily withdrew the pill and is now refocusing on injectable therapy.
Yes. During your intake we review your current dose and date of last injection. Our clinicians can schedule your first shipment so it arrives before your next dose is due, minimizing overlap or missed weeks.
Novolene automatically generates an itemized receipt with the diagnostic and drug codes required for HSA/FSA reimbursement. Hims offers similar paperwork, but because their platform bundles non-qualifying cosmetic products, claims can be more complex to itemize.
Take our 3-minute clinical intake. A licensed clinician will review your history and calculate the best GLP-1 option for your goals.
Start My Evaluation